The High Cost of Insulin: Bridging Gaps on the Path to Affordable Care
Cardiometabolic Health Congress
JANUARY 19, 2024
Novo Nordisk lowered list prices on several of its insulin products by up to 75% and continues to run programs that cap insulin costs at $25-35 for eligible patients. However, increasing government and activist pressure has forced manufacturers to lower insulin costs.
Let's personalize your content